Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
PainChek Ltd ( (AU:PCK) ) just unveiled an announcement.
PainChek Limited has disclosed a change in the interests of director John Murray, who has allowed 40,000 options held indirectly through Nanjop Pty Ltd as trustee for the Murring Family Trust to lapse, resulting in no remaining options and no change to his total shareholding in the company. Following the lapse, Murray continues to hold 1,463,860 fully paid ordinary shares indirectly and 390,600 fully paid ordinary shares directly, a development that slightly alters the structure of his equity exposure by removing option-based incentives but leaves his direct and indirect share ownership unchanged, with no on-market trades reported and no closed-period trading issues raised.
More about PainChek Ltd
PainChek Limited is an Australian-listed company that operates in the healthcare technology sector. The company develops and commercialises digital tools for pain assessment, with a focus on clinical and aged care environments, using software-based solutions to improve the detection and monitoring of pain in patients who may have difficulty communicating their symptoms.
Average Trading Volume: 470,756
Technical Sentiment Signal: Sell
Current Market Cap: A$61.66M
For a thorough assessment of PCK stock, go to TipRanks’ Stock Analysis page.